Condition
Non-Segmental Vitiligo (NSV)
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 2 (3)
Trial Status
Recruiting3
Not Yet Recruiting2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07533019Phase 2Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07625891Phase 2Recruiting
Study of D-2570 in Subjects With Non-Segmental Vitiligo
NCT07673640Not Yet RecruitingPrimary
Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study
NCT07556471Phase 2Not Yet RecruitingPrimary
Evaluation of the Efficacy and Safety of LW402 Tablets in Patients With Non-Segmental Vitiligo
NCT07136467RecruitingPrimary
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Showing all 5 trials